The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement PICI Network Researchers to Present #SITC22 Announcement Dana-Farber and Gladstone Institutes Join PICI Network Announcement, Our Impact Parker Institute Researchers Featured at #CICON22 Announcement, Our Impact Latest Pancreatic Cancer Findings Highlighted Announcement, Our Impact #ESMO22 Features Six PICI Network Researchers Announcement, Our Impact Researchers Present at UK Brain Tumour Conference Announcement, Partner Highlight, Press Release Collaboration Speeds Access to Clinical Trial Services
Announcement, Partner Highlight, Press Release Collaboration Speeds Access to Clinical Trial Services